FDA Approved: BETOPTIC S — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for BETOPTIC S (betaxolol hydrochloride) submitted by Novartis, resulting in labeling changes for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• BETOPTIC S (betaxolol hydrochloride)

Snippet

SUPPL AP for BETOPTIC S (BETAXOLOL HYDROCHLORIDE)